This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

No Free Lunch in Spam

You might call them the Dogs of the Dogs. Wall Street has saluted them with a raised hind leg, and they languish in over-the-counter kennels where there are thousands of better managed companies that a thoughtful, intelligent investor would, after careful inspection, prefer to adopt.

But maybe you don't always inspect so carefully. And look at them: Those poor, neglected mongrels are hungry for your attention -- or even better, your money. Luckily, there is someone who wants to introduce you to them.

Sure, it's an anonymous someone, a person so desperate to hide his identity he's forged the email headers. Maybe it's just a Good Samaritan so humble he wants to perform his virtuous acts in secret? Well, he certainly believes in these dogs. Just listen to this: "Possibly the drug discovery of the decade!" Or this: "Will grow like Wal-Mart and produce even greater shareholder profits!"

Sound familiar? Unless you've taken extraordinary measures to keep your email address private, you've received a blizzard of these stock pitches. You'd think a "stock of the decade" would come ... well ... once every 10 years. Yet I've been graciously informed of five of them this week alone. Like me, you probably filter or delete them all.

One guy, Joshua Cyr, didn't delete them. He didn't invest in any of them either, but he did add 1,000 shares of each spam-touted stock to a mock portfolio and then monitored them for a few months. Through May and June, Cyr added 37 stocks and decided that was a good-enough sampling, even though the spam kept flooding him with even more once-in-a-lifetime, ground-floor opportunities -- 955 spams at last count, he says.

That Cyr's spam portfolio, which he maintains on a Web site he created called SpamStockTracker.com, hasn't done terribly well isn't at all a surprise. What is interesting, however, is just how amazingly bad it's performed.
1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
GOOG $520.60 -0.18%
AAPL $125.42 0.72%
FB $85.76 -0.04%
TSLA $268.26 2.38%
YHOO $39.29 0.98%

Markets

DOW 17,619.51 +23.16 0.13%
S&P 500 2,063.12 +5.48 0.27%
NASDAQ 4,986.8670 +28.3990 0.57%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs